pocket.md
  pocket.md 
  pocket.md 
pocket.md
pocket.md pocket.md
pocket.md
 
pocket.md
pocket.md
    All APPS
Search
2

Medical & Healthcare apps of Acorda Therapeutics, Inc. are listed with us

Acorda Therapeutics, Inc.

Acorda Therapeutics, Inc. (Acorda) is a commercial-stage biopharmaceutical company. The Company is engaged in the identification, development and commercialization of novel therapies that improve neurological function in people with multiple sclerosis (MS), spinal cord injury (SCI), and other disorders of the nervous system. Ampyra (dalfampridine) is an extended release tablet formulation of dalfampridine (4-aminopyridine, 4-AP). It also sells Zanaflex Capsules and Zanaflex tablets, which contain tizanidine hydrochloride, a short-acting drug for the management of spasticity. Ampyra is marketed as Fampyra outside the United States by Biogen Idec International GmbH (Biogen Idec). On February 6, 2012, the Company launched tizanidine hydrochloride capsules, an authorized generic version of Zanaflex Capsules under an agreement with Watson Pharma, Inc. In December 2012, the Company acquired Neuronex, Inc.

Total  2 Record(s) Found
 
MS self – Multiple Sclerosis Mobile App for iPad
iPad
Acorda Thera
4 Ratings
Free
MS self – Multiple Scl
If you have been diagnosed with multiple sclerosis, you understand the ways it m...
MS self – Multiple Sclerosis Mobile App for iPhone
iPhone
Acorda Thera
0 Ratings
Free
MS self – Multiple Scl
If you have been diagnosed with multiple sclerosis, you understand the ways it m...
Total  2 Record(s) Found
 
 
 
Home  |   Applications  |   Sitemap  |   Contact Us  |   Terms & Conditions  |   Privacy Policy  |   FAQs
 
 

  Dear User,

We have introduced "SUBSCRIBE"

New feature in our site where we are giving away free app reports about your favourite apps, companies and condition.

Please visit and subscribe to get your app reports.